Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use
of eflornithine and diclofenac may stop cancer from growing in patients with sun-damaged
skin.
PURPOSE: This randomized phase II trial is studying the side effects and how well
eflornithine works compared with diclofenac, given alone or together, in treating patients
with sun-damaged skin.